Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The project will transport more ...
In a recent exclusive interview, Fierce Biotech’s Chris Hayden sat down with Alex MacDonald, Vice President of Model-Informed Drug Development at Allucent, to explore the impact of Project Optimus, an ...
Project portfolio selection and optimisation is a multifaceted discipline that integrates advanced mathematical modelling and decision analysis to support the allocation of limited resources among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results